Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
275 studies found for:    Open Studies | UCSD OR UC San Diego OR VA San Diego
Show Display Options
Rank Status Study
21 Recruiting Avelumab for Recurrent/Metastatic Nasopharyngeal Cancer
Condition: Nasopharyngeal Cancer
Intervention: Drug: Avelumab
22 Recruiting Nivolumab in Combination With Plinabulin in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC)
Condition: Non-small Cell Lung Cancer Metastatic
Intervention: Drug: Nivolumab + Plinabulin
23 Recruiting Dimethylfumarate (DMF) in Relapsed/Refractory CLL/SLL
Conditions: Chronic Lymphocytic Leukemia;   Small Lymphocytic Lymphoma
Intervention: Drug: dimethyl fumarate
24 Recruiting Safety and Effect of GL-ONC1 Administered IV With or Without Eculizumab Prior to Surgery to Patients With Solid Organ Cancers Undergoing Surgery
Condition: Solid Organ Cancers
Interventions: Biological: GL-ONC1;   Biological: Eculizumab
25 Recruiting SF1126 in Recurrent or Progressive SCCHN and Mutations in PIK3CA Gene and/or PI-3 Kinase Pathway Genes
Condition: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
Intervention: Drug: SF1126
26 Not yet recruiting Lenalidomide and Obinutuzumab for Previously Untreated CLL
Condition: Chronic Lymphocytic Leukemia
Interventions: Drug: Lenalidomide;   Drug: Obinutuzumab
27 Not yet recruiting Evaluation of the Immune Restoration Potential Of Lenalidomide
Condition: Chronic Lymphocytic Leukemia (CLL)
Intervention: Drug: Lenalidomide
28 Recruiting Impact of Combined Behavioral Interventions on Cognitive Outcomes in MCI
Condition: Mild Cognitive Impairment
Interventions: Behavioral: Walking Intervention;   Behavioral: Cognitive Training Intervention;   Behavioral: Combined Intervention
29 Recruiting Studying the Effectiveness of Non-Invasive Glucose Sensors in Patients With Diabetes: The SENSOR Study
Condition: Diabetes Mellitus
Intervention: Device: Wearing a non-invasive glucose sensor
30 Recruiting Improving Negative Symptoms of Psychosis In Real-world Environments
Condition: Schizophrenia
Interventions: Behavioral: CBSST-CCT;   Behavioral: Goal focused supportive contact
31 Recruiting Real-Time Mobile Cognitive Behavioral Intervention for Serious Mental Illness
Conditions: Schizophrenia;   Bipolar Disorder
Interventions: Behavioral: CBT2go;   Device: Smartphone
32 Recruiting Agitated Saline, Albumin, or Propofol-albumin Mixture for Enhanced Contrast in TEE Examinations
Condition: Transesophageal Echocardiography Contrast Agents
Interventions: Drug: normal saline;   Drug: human albumin;   Drug: human albumin and propofol
33 Not yet recruiting Effect of Cannabis and Endocannabinoids on HIV Neuropathic Pain
Conditions: Cannabis;   HIV Neuropathy;   Pain Syndrome
Intervention: Drug: Cannabis
34 Recruiting Using a Field Performance Test on an iPad to Evaluate Driving Under the Influence of Cannabis
Condition: Cannabis Intoxication
Intervention: Drug: cannabis
35 Recruiting Trial of Dronabinol and Vaporized Cannabis in Neuropathic Low Back Pain
Conditions: Cannabis;   Low Back Pain;   Neuropathic Pain
Interventions: Drug: Placebos;   Drug: dronabinol;   Drug: Vaporized Cannabis 3.7% THC/5.6% CBD
36 Recruiting U.S. CTEPH Registry
Conditions: Chronic Thromboembolic Pulmonary Hypertension (CTEPH);   Pulmonary Hypertension
Intervention:
37 Recruiting Lumbar Drain vs Extraventricular Drain to Prevent Vasospasm in Subarachnoid Hemorrhage
Conditions: Vasospasm, Intracranial;   Subarachnoid Hemorrhage
Interventions: Device: Extraventricular Drain;   Device: Lumbar Drain
38 Recruiting Effect of Mode of Transport Ventilation on Respiratory Parameters After Cardiac Surgery
Condition: Complication of Ventilation Therapy
Intervention:
39 Not yet recruiting Histology-Independent Study of Palbociclib in Patients With Advanced Cancer
Condition: Cancer, Advanced
Intervention: Drug: Palbociclib 125mg
40 Not yet recruiting A Study of the Cirmtuzumab and Ibrutinib in Patients With B-Cell Lymphoid Malignancies
Conditions: B-cell Chronic Lymphocytic Leukemia;   Small Lymphocytic Lymphoma;   Mantle Cell Lymphoma
Interventions: Drug: Cirmtuzumab;   Drug: Ibrutinib;   Drug: Cirmtuzumab plus ibrutinib

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.